Education
About Us
Working with TipRanks
Follow Us
Crescent Biopharma (CBIO)
NASDAQ:CBIO
Crescent Biopharma (CBIO) Ownership Overview
The ownership structure of Crescent Biopharma (CBIO) stock is a mix of institutional, retail, and individual investors. , 0.45% is owned by Insiders, and 80.21% is owned by Public Companies and Individual Investors.
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2025 | xxxxxxxxxxxxx | $1220409 | |
Jun 30, 2025 | xxxxxxxxxxxxx | $4881655 | |
Jun 30, 2025 | xxxxxxxxxxxxx | $7322492 | |
Jun 30, 2025 | xxxxxxxxxxxxx | $22400157 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,387,866 | Institution | 9.99% | 15,669,007 | |
| 453,686 | Institution | 3.27% | 5,122,115 | |
| 302,457 | Institution | 2.18% | 3,414,740 | |
| 75,614 | Institution | 0.54% | 853,682 | |
| 62,383 | Insider | 0.45% | 704,304 | |
| 26,557 | Institution | 0.19% | 299,829 | |
| 23,860 | Institution | 0.17% | 269,379 | |
| 5,169 | Institution | 0.04% | 58,358 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 26,557 | Institution | 0.19% | 299,829 | |
| 5,169 | Institution | 0.04% | 58,358 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 514,841 | Institution | 3.71% | 6,121,459 | |
| 81,936 | Institution | 0.59% | 974,219 |
FAQ
Who Owns Crescent Biopharma (CBIO)?
Currently, no data Available
What percentage of Crescent Biopharma (CBIO) stock is held by institutional investors?
Currently, no data Available
What percentage of Crescent Biopharma (CBIO) stock is held by retail investors?
According to the latest TipRanks data, approximately 80.21% of Crescent Biopharma (CBIO) stock is held by retail investors.
Who owns the most shares of Crescent Biopharma (CBIO)?
Peter Harwin owns the most shares of Crescent Biopharma (CBIO).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.